Welcome to LookChem.com Sign In|Join Free

CAS

  • or

923289-59-2

Post Buying Request

923289-59-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

923289-59-2 Usage

General Description

4-Isopropylthiazole-2-carbonyl chloride is a chemical compound that belongs to the thiazole class. It is used in organic synthesis as a versatile building block for the preparation of various pharmaceuticals and agrochemicals. 4-Isopropylthiazole-2-carbonyl chloride is known for its strong potential as an intermediate in the production of thiazole-based compounds, which have applications in the pharmaceutical industry. Additionally, it serves as a key starting material for the synthesis of biologically active molecules and can be utilized in the development of new drugs and medicinal compounds. Its unique structure and properties make it a valuable tool for synthetic chemists and researchers in the development of novel organic molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 923289-59-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,3,2,8 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 923289-59:
(8*9)+(7*2)+(6*3)+(5*2)+(4*8)+(3*9)+(2*5)+(1*9)=192
192 % 10 = 2
So 923289-59-2 is a valid CAS Registry Number.

923289-59-2Relevant articles and documents

2-(1H-INDOLE-3-CARBONYL)-THIAZOLE-4-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS ARYL HYDROCARBON RECEPTOR (AHR) AGONISTS FOR THE TREATMENT OF E.G. ANGIOGENESIS IMPLICATED OR INFLAMMATORY DISORDERS

-

, (2021/06/26)

2-(1H-lndole-3-carbonyl)-thiazole-4-carboxamide derivatives and the corresponding imidazole, oxazole and thiophene derivatives and related compounds as aryl hydrocarbon receptor (AHR) agonists for the treatment of angiogenesis implicated disorders, such as e.g. retinopathy, psoriasis, rheumatoid arthritis, obesity and cancer, or inflammatory disorders. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 27 to 32 and 59 to 219; examples 1 to 8; compounds 1-1 to 1-97; tables 1-a, 2 and 3).

COMPOUNDS AS HEPATITIS C INHIBITORS AND USES THEREOF IN MEDICINE

-

, (2016/09/22)

Provided herein are compounds as hepatitis C inhibitors and uses thereof in medicine. Specifically, provided herein is a compound of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or hepatitis C diseases. Also provided herein are a pharmaceutically acceptable composition containing such compound and a method of treating HCV infection or hepatitis C diseases comprising administering the compound or pharmaceutical composition thereof disclosed herein.

MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV

-

, (2011/02/24)

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula (Ia) or (Ib), pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 923289-59-2